ArticleEndocrinology, diabetes & metabolism2025
Obstructive Sleep Apnoea and Risk of Fragility Fracture in Patients With Type 2 Diabetes: A Population-Based Retrospective Cohort Study.
Article in Endocrinology, diabetes & metabolism, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Obstructive Sleep Apnoea and Risk of Fragility Fracture in Patients With Type 2 Diabetes: A Population-Based Retrospective Cohort Study.Endocrinology, diabetes & metabolism · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
objectiveThis study examines the risk of fragility fractures in patients with type 2 diabetes (T2D) who have obstructive sleep apnoea (OSA) compared to those without OSA.
methodThis retrospective cohort study uses UK primary care data from 2000 to 2022. T2D patients without prior fragility fractures were included. Patients with OSA were matched with up to 4 non-OSA patients based on age, sex, BMI and T2D duration. Two cohorts were analysed based on whether OSA was diagnosed before (cohort 1) or after (cohort 2) the T2D diagnosis. Hazard ratios were calculated using a Cox proportional hazards model.
resultsCohort 1 included 19,795 patients with OSA and 64,124 without OSA. Cohort 2 included 21,769 patients with OSA and 66,350 without OSA. OSA was associated with an increased risk of incident fragility fractures in both cohorts [aHR (95% CI): 1.12 (1.00-1.25); p = 0.04, and 1.15 (1.05-1.26; p = 0.002), respectively]. The point estimates of the subgroup analysis by age and gender of cohort 1 suggest an association between OSA and the risk of fractures in men and in those above 50 years old. In cohort 2, the subgroup analysis point estimate suggests an association between OSA and fragility fractures in men and women and those above and below 50 years old.
conclusionOSA is associated with an increased fragility fracture risk in T2D patients. Further studies are needed to determine if treating OSA reduces this risk. Clinicians should consider bone health and fracture risk, particularly for older patients.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.